The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin

Nephrology Dialysis Transplantation

Volumn 16, Issue 7, 2001, Pages 1416-1423

  Tessitore, Nicola ^a,b   Solero, Giovanni Pietro ^a   Lippi, Giuseppe ^a   Bassi, Antonella ^a   Faccini, Giovanni Battista ^a   Bedogna, Valeria ^a   Gammaro, Linda ^a   Brocco, Giorgio ^a   Restivo, Giuseppe ^a   Bernich, Patrizia ^a   Lupo, Antonio ^a   Maschio, Giuseppe ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b Servizio Emodialisi Ospedale Policlinico   (Italy)

Author keywords

Erythrocytes; Erythropoietin; Haemodialysis; Iron deficiency; Percentage hypochromic; Reticulocyte haemoglobin content; Soluble transferrin receptor

Indexed keywords

BIOCHEMICAL MARKER; ERYTHROPOIETIN; FERRIC GLUCONATE; FERRITIN; HEMOGLOBIN; IRON; PROTOPORPHYRIN ZINC; TRANSFERRIN RECEPTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DRUG RESPONSE; ERYTHROCYTE; FEMALE; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY; IRON THERAPY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PARAMETER; PATIENT CODING; PATIENT MONITORING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETICULOCYTE;

EID: 0034945056     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.7.1416     Document Type: Article

References (26)

1. Correction of the anemia of end stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trials
2. Erythropoiesis and iron supply in patients treated with erythropoietin
3. The evaluation of iron status in hemodialysis patients
4. Detection of functional iron deficiency during erythropoietin treatment: A new approach
5. European best practice guidelines for the management of anaemia in patients with chronic renal failure
6. Percentage of hypochromic red cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients
7. Percentage hypochromic red cells and the response to intravenous iron therapy in anaemic haemodialysis patients
8. Iron status and low dose intravenous Fe gluconate in hemodialysis patients on maintenance erythropoietin
9. Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis
10. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients
11. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO
12. The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients
13. Erythrocyte zinc protoporphyrin
14. The importance of serum transferrin receptor level in the diagnosis of functional iron deficiency due to recombinant human erythropoietin treatment in hemodialysis patients
15. Factors determining the percentage of hypochromic red blood cells in hemodialysis patients
16. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure
17. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients
18. Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy
19. Reticulocyte hemoglobin content: Is it useful in the evaluation of iron status in hemodialysis patients?
20. Reticulocyte indices in patients with end stage renal disease in hemodialysis
21. Prospective evaluation of reticulocyte hemoglobin content (CHr) to predict functional iron deficiency in hemodialysis
22. Zinc protoporphyrin and iron-deficient erythropoiesis
23. Iron deficiency in maintenance hemodialysis patients: Assessment of diagnosis criteria and of three different iron treatments
24. An indistinct balance: The safety and efficacy of parenteral iron
25. NKF-DOQI Clinical practice guidelines for the treatment of anemia of chronic renal failure